131 |
Prescription Drug Abuse a Decade into the Epidemic: Lessons Learned in TennesseePack, Robert P. 12 July 2016 (has links)
No description available.
|
132 |
Prescription Drug Abuse Prevention Efforts at ETSUPack, Robert P., Hagemeier, Nicholas 25 September 2013 (has links)
No description available.
|
133 |
Yearly Trends in Controlled Substances Obtained via Permanent Drug Donation Boxes in Northeast TennesseeSevak, Rajkumar J., Brooks, Billy, Gray, Jeffrey A., Alamian, Arsham, Hagemeier, Nicholas E., Pack, Robert P. 01 April 2015 (has links)
Abstract available through the Journal of Pharmacy Practice.
|
134 |
Correlates of Prescription Opioid Legitimacy Estimations among Community Pharmacists in TennesseeHagemeier, Nicholas E., Alamian, Arsham, Murawski, M. M., Pack, Robert P., Flippin, H., Hagy, H. 16 June 2015 (has links)
Abstract available through Drug and Alcohol Dependence.
|
135 |
The ETSU Prescription Drug Abuse/Misuse Working Group: A Case Study for Inter-professional Research and Training in South Central AppalachiaBrooks, Billy, Warfield, S., Pack, Robert P., Gray, Jeffrey A., Alamian, Arsham, Hagaman, A. M., Hagemeier, Nicholas E. 27 March 2015 (has links)
No description available.
|
136 |
The Science of Safety: Pharmacists and the Opioid CrisisHagemeier, Nicholas E. 16 July 2017 (has links)
No description available.
|
137 |
Methadone for the Treatment of Opioid Use DisordersHagemeier, Nicholas E., White, L. 07 March 2017 (has links)
No description available.
|
138 |
Prescription Drug Abuse: Regional Realities and RecommendationsMelton, Sarah, Hagemeier, Nicholas E. 17 August 2016 (has links)
No description available.
|
139 |
Looking Beyond Red FlagsHagemeier, Nicholas E. 30 March 2016 (has links)
The presentation will look beyond red flags to inform Rx legitimacy judgments and subsequent prescribing and dispensing decisions. The presenter will describe the outcomes of two research projects that examined prescribers’ and pharmacists’ perceptions of Rx legitimacy and Rx drug abuse communication behaviors. Attendees will gain insight into the process of evaluating Rx legitimacy and learn how subjectivity inherent in these judgments influences prescribing and dispensing behaviors and patient care. The presenter also will identify evidencebased, practice-friendly interventions to engage community pharmacists in community-based prevention of Rx drug abuse and its consequences.
|
140 |
Improving Tennessee Health Care Providers Understanding of Neonatal Abstinence SyndromeClick, Ivy, Hagemeier, Nicholas E. 13 March 2015 (has links)
No description available.
|
Page generated in 0.0816 seconds